Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Teclison Ltd.
Teclison Ltd.
National Institutes of Health Clinical Center (CC)
Instituto do Cancer do Estado de São Paulo
National Cancer Institute (NCI)
RayzeBio, Inc.
Turning Point Therapeutics, Inc.
RayzeBio, Inc.
Boston Scientific Corporation
Methodist Health System
Novartis
Centre Oscar Lambret
Huazhong University of Science and Technology
Hoffmann-La Roche
Cedars-Sinai Medical Center
University of Florida
Jonsson Comprehensive Cancer Center
Chimeric Therapeutics
SAPU NANO (US) LLC
Barbara Ann Karmanos Cancer Institute
University of Nebraska
Guerbet
IRCCS San Raffaele
Imperial College London
University Hospital, Strasbourg, France
TaiRx, Inc.
University of Iowa
ITM Solucin GmbH
Tanabe Pharma America, Inc.
Nantes University Hospital
Perspective Therapeutics
Massive Bio, Inc.
Novelty Nobility, Inc.
Merck Sharp & Dohme LLC
Cook Group Incorporated
ITM Solucin GmbH
Barbara Ann Karmanos Cancer Institute
Jonsson Comprehensive Cancer Center
University of Pittsburgh
PharmaMar
Nuvation Bio Inc.
Hoffmann-La Roche
Abramson Cancer Center at Penn Medicine
Hutchmed
Case Comprehensive Cancer Center
IRCCS San Raffaele
Nanjing First Hospital, Nanjing Medical University
UNICANCER
Second Affiliated Hospital, School of Medicine, Zhejiang University
Grupo Espanol de Tumores Neuroendocrinos
Western Sydney Local Health District